Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chin-Pang Yiu
Prediction of the SARS-CoV-2 (2019-nCoV) 3c-Like Protease (3CLpro) Structure: Virtual Screening Reveals Velpatasvir, Ledipasvir, and Other Drug Repurposing Candidates
Related publications
Prediction of the SARS-CoV-2 (2019-nCoV) 3c-Like Protease (3CLpro) Structure: Virtual Screening Reveals Velpatasvir, Ledipasvir, and Other Drug Repurposing Candidates
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Inhibition of SARS-CoV 3c-Like Protease Activity by Theaflavin-3,3'-Digallate (TF3)
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
Virus Against Virus: A Potential Treatment for 2019-nCov (SARS-CoV-2) and Other RNA Viruses
Cell Research
Cell Biology
Molecular Biology
In Silico Repositioning for Dual Inhibitor Discovery of SARS-CoV-2 (COVID-19) 3c-Like Protease and Papain-Like Peptidase
Scutellaria Baicalensis Extract and Baicalein Inhibit Replication of SARS-CoV-2 and Its 3c-Like Protease in Vitro
Comparative Genetic Analysis of the Novel Coronavirus (2019-nCoV/SARS-CoV-2) Receptor ACE2 in Different Populations
Cell Discovery
Biochemistry
Genetics
Cell Biology
Molecular Biology
Computational Target-Based Drug Repurposing of Elbasvir, an Antiviral Drug Predicted to Bind Multiple SARS-CoV-2 Proteins
Characteristics of Flavonoids as Potent MERS ‐CoV 3C‐like Protease Inhibitors
Chemical Biology and Drug Design
Biochemistry
Organic Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
Isatin Compounds as Noncovalent SARS Coronavirus 3c-Like Protease Inhibitors
